Patents by Inventor Nathaniel Ross Liddy
Nathaniel Ross Liddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230322895Abstract: The present invention relates to T cell receptors (TCRs) that bind the HLA-A*02 restricted peptide GVYDGREHTV (SEQ ID NO: 1) derived from the germline cancer antigen MAGE A4. Said TCRs may comprise non-natural mutations within the alpha and/or beta variable domains relative to a native MAGE A4 TCR. The TCRs of the invention are particularly suitable for use as novel immunotherapeutic reagents for the treatment of malignant disease.Type: ApplicationFiled: October 13, 2022Publication date: October 12, 2023Inventors: Conor HAYES, Linda HIBBERT, Nathaniel Ross LIDDY, Tara MAHON, Marine RAMAN
-
Patent number: 11739442Abstract: The present invention relates to a library of particles, the library displaying a plurality of different T cell receptors (TCRs), wherein the plurality of TCRs consists essentially of TCRs comprising an alpha chain variable domain and a beta chain variable domain, wherein the alpha chain variable domain comprises a TRAV12-2 gene product and the beta chain variable domain comprises a TRBV gene product.Type: GrantFiled: August 19, 2021Date of Patent: August 29, 2023Assignees: Immunocore Limited, Adaptimune LimitedInventors: Bent Karsten Jakobsen, Nathaniel Ross Liddy, Peter Eamon Molloy, Annelise Brigitte Vuidepot
-
Patent number: 11505590Abstract: The present invention relates to T cell receptors (TCRs) that bind the HLA-A*02 restricted peptide GVYDGREHTV (SEQ ID NO: 1) derived from the germline cancer antigen MAGE A4. Said TCRs may comprise non-natural mutations within the alpha and/or beta variable domains relative to a native MAGE A4 TCR. The TCRs of the invention are particularly suitable for use as novel immunotherapeutic reagents for the treatment of malignant disease.Type: GrantFiled: April 7, 2017Date of Patent: November 22, 2022Assignee: IMMUNOCORE LIMITEDInventors: Conor Hayes, Linda Hibbert, Nathaniel Ross Liddy, Tara Mahon, Marine Raman
-
Publication number: 20220235113Abstract: The present invention relates to a library of particles, the library displaying a plurality of different T cell receptors (TCRs), wherein the plurality of TCRs may consist essentially of TCRs which may comprise an alpha chain variable domain from a natural repertoire and a beta chain variable domain from a natural repertoire, wherein the alpha chain variable domain may comprise a TRAV12-2 or a TRAV21 gene product and the beta chain variable domain may comprise a TRBV6 gene product.Type: ApplicationFiled: April 12, 2022Publication date: July 28, 2022Inventors: Bent Karsten Jakobsen, Peter Eamon Molloy, Annelise Brigitte Vuidepot, Nathaniel Ross Liddy
-
Publication number: 20210395332Abstract: The present invention relates to a library of particles, the library displaying a plurality of different T cell receptors (TCRs), wherein the plurality of TCRs consists essentially of TCRs comprising an alpha chain variable domain and a beta chain variable domain, wherein the alpha chain variable domain comprises a TRAV12-2 gene product and the beta chain variable domain comprises a TRBV gene product.Type: ApplicationFiled: August 19, 2021Publication date: December 23, 2021Inventors: Bent Karsten Jakobsen, Nathaniel Ross Liddy, Peter Eamon Molloy, Annelise Brigitte Vuidepot
-
Publication number: 20210371493Abstract: The present invention relates to a library of particles, the library displaying a plurality of different T cell receptors (TCRs), wherein the plurality of TCRs may consist essentially of TCRs which may comprise an alpha chain variable domain from a natural repertoire and a beta chain variable domain from a natural repertoire, wherein the alpha chain variable domain may comprise a TRAV12-2 or a TRAV21 gene product and the beta chain variable domain may comprise a TRBV6 gene product.Type: ApplicationFiled: May 28, 2021Publication date: December 2, 2021Inventors: Bent Karsten JAKOBSEN, Peter Eamon MOLLOY, Annelise Brigitte VUIDEPOT, Nathaniel Ross LIDDY
-
Patent number: 11124556Abstract: The present invention relates to a library of particles, the library displaying a plurality of different T cell receptors (TCRs), wherein the plurality of TCRs consists essentially of TCRs comprising an alpha chain variable domain and a beta chain variable domain, wherein the alpha chain variable domain comprises a TRAV12-2 gene product and the beta chain variable domain comprises a TRBV gene product.Type: GrantFiled: September 15, 2016Date of Patent: September 21, 2021Assignees: Immunocore Limited, Adaptimmune LimitedInventors: Bent Karsten Jakobsen, Nathaniel Ross Liddy, Peter Eamon Molloy, Annelise Brigitte Vuidepot
-
Publication number: 20190153062Abstract: The present invention relates to a library of particles, the library displaying a plurality of different T cell receptors (TCRs), wherein the plurality of TCRs consists essentially of TCRs comprising an alpha chain variable domain and a beta chain variable domain, wherein the alpha chain variable domain comprises a TRAV17 gene product and the beta chain variable domain comprises a TRBV2 gene product.Type: ApplicationFiled: September 15, 2016Publication date: May 23, 2019Inventors: Annelise Brigitte Vuidepot, Bent Karsten Jakobsen, Nathaniel Ross Liddy, Peter Eamon Molloy
-
Publication number: 20190092834Abstract: The present invention relates to T cell receptors (TCRs) that bind the HLA-A*02 restricted peptide GVYDGREHTV (SEQ ID NO: 1) derived from the germline cancer antigen MAGE A4. Said TCRs may comprise non-natural mutations within the alpha and/or beta variable domains relative to a native MAGE A4 TCR. The TCRs of the invention are particularly suitable for use as novel immunotherapeutic reagents for the treatment of malignant disease.Type: ApplicationFiled: April 7, 2017Publication date: March 28, 2019Inventors: Conor HAYES, Linda HIBBERT, Nathaniel Ross LIDDY, Tara MAHON, Marine RAMAN
-
Publication number: 20190048058Abstract: The present invention relates to a library of particles, the library displaying a plurality of different T cell receptors (TCRs), wherein the plurality of TCRs consists essentially of TCRs comprising an alpha chain variable domain and a beta chain variable domain, wherein the alpha chain variable domain comprises a TRAV12-2 gene product and the beta chain variable domain comprises a TRBV gene product.Type: ApplicationFiled: September 15, 2016Publication date: February 14, 2019Inventors: Bent Karsten Jakobsen, Nathaniel Ross Liddy, Peter Eamon Molloy, Annelise Brigitte Vuidepot
-
Publication number: 20190048059Abstract: The present invention relates to a library of particles, the library displaying a plurality of different T cell receptors (TCRs), wherein the plurality of TCRs consists essentially of TCRs comprising an alpha chain variable domain and a beta chain variable domain, wherein the alpha chain variable domain comprises a TRAV9-2 gene product and the beta chain variable domain comprises a TRBV9 gene product.Type: ApplicationFiled: September 15, 2016Publication date: February 14, 2019Inventors: Bent Karsten Jakobsen, Nathaniel Ross Liddy, Peter Eamon Molloy, Annelise Brigitte Vuidepot
-
Publication number: 20180346904Abstract: The present invention relates to a library of particles, the library displaying a plurality of different T cell receptors (TCRs), wherein the plurality of TCRs consists essentially of TCRs comprising an alpha chain variable domain and a beta chain variable domain, wherein the alpha chain variable domain comprises a TRAV38 gene product and the beta chain variable domain comprises a TRBV2 gene product.Type: ApplicationFiled: September 15, 2016Publication date: December 6, 2018Applicants: IMMUNOCORE LIMITED, ADAPTIMMUNE LIMITEDInventors: Bent Karsten Jakobsen, Nathaniel Ross Liddy, Peter Eamon Molloy, Annelise Brigitte Vuidepot
-
Publication number: 20180346903Abstract: The present invention relates to a library of particles, the library displaying a plurality of different T cell receptors (TCRs), wherein the plurality of TCRs consists essentially of TCRs comprising an alpha chain variable domain and a beta chain variable domain, wherein the alpha chain variable domain comprises a TRAV27 gene product and the beta chain variable domain comprises a TRBV9 gene product.Type: ApplicationFiled: September 15, 2016Publication date: December 6, 2018Inventors: Bent Karsten Jakobsen, Nathaniel Ross Liddy, Peter Eamon Molloy, Annelise Brigitte Vuidepot
-
Publication number: 20180340168Abstract: The present invention relates to a library of particles, the library displaying a plurality of different T cell receptors (TCRs), wherein the plurality of TCRs consists essentially of TCRs comprising an alpha chain variable domain and a beta chain variable domain, wherein the alpha chain variable domain comprises a TRAV21 gene product and the beta chain variable domain comprises a TRBV5 gene product.Type: ApplicationFiled: September 15, 2016Publication date: November 29, 2018Inventors: Bent Karsten Jakobsen, Peter Eamon Molloy, Annelise Brigitte Vuidepot, Nathaniel Ross Liddy
-
Publication number: 20180340167Abstract: The present invention relates to a library of particles, the library displaying a plurality of different T cell receptors (TCRs), wherein the plurality of TCRs consists essentially of TCRs comprising an alpha chain variable domain and a beta chain variable domain, wherein the alpha chain variable domain comprises a TRAV13-1 gene product and the beta chain variable domain comprises a TRBV4 gene product.Type: ApplicationFiled: September 15, 2016Publication date: November 29, 2018Inventors: Bent Karsten Jakobsen, Nathaniel Ross Liddy, Peter Eamon Molloy, Annelise Brigitte Vuidepot
-
Publication number: 20170051036Abstract: The present invention relates to a library of particles, the library displaying a plurality of different T cell receptors (TCRs), wherein the plurality of TCRs may consist essentially of TCRs which may comprise an alpha chain variable domain from a natural repertoire and a beta chain variable domain from a natural repertoire, wherein the alpha chain variable domain may comprise a TRAV12-2 or a TRAV21 gene product and the beta chain variable domain may comprise a TRBV6 gene product.Type: ApplicationFiled: September 12, 2016Publication date: February 23, 2017Inventors: Bent Karsten JAKOBSEN, Peter Eamon MOLLOY, Annelise Brigitte VUIDEPOT, Nathaniel Ross LIDDY
-
Patent number: 9068178Abstract: A T cell receptor (TCR) having the property of binding to the gp100 YLEPGPVTA peptide-HLA-A2 complex and comprising a TCR alpha variable domain and/or a TCR beta variable domain, characterized in that the domains are mutated relative to a TCR having the extracellular alpha and beta chain sequences SEQ ID NOs: 2 and that the TCR has a binding affinity for, and/or a binding half-life for, the YLEPGPVTA-HLA-A2 complex at least double that of a reference TCR. Embodiments of the invention such as the use of such TCRs in adoptive therapy, and fusions of such TCRs with therapeutic agents are also described.Type: GrantFiled: July 22, 2013Date of Patent: June 30, 2015Assignee: IMMUNOCORE LTD.Inventors: Bent Karsten Jakobsen, Naomi Harwood, Nathaniel Ross Liddy
-
Publication number: 20140099699Abstract: A T cell receptor (TCR) having the property of binding to the gp100 YLEPGPVTA peptide-HLA-A2 complex and comprising a TCR alpha variable domain and/or a TCR beta variable domain, characterized in that the domains are mutated relative to a TCR having the extracellular alpha and beta chain sequences SEQ ID NOs: 2 and that the TCR has a binding affinity for, and/or a binding half-life for, the YLEPGPVTA-HLA-A2 complex at least double that of a reference TCR. Embodiments of the invention such as the use of such TCRs in adoptive therapy, and fusions of such TCRs with therapeutic agents are also described.Type: ApplicationFiled: July 22, 2013Publication date: April 10, 2014Applicant: IMMUNOCORE LIMITEDInventors: Bent Karsten Jakobsen, Naomi Harwood, Nathaniel Ross Liddy
-
Patent number: 8283446Abstract: A T cell receptor (TCR) having the property of binding to EVDPIGHLY HLA-A1 complex and comprising a specified wild type TCR which has specific mutations in the TCR alpha variable domain and/or the TCR beta variable domain to increase affinity. Such TCRs are useful for adoptive therapy.Type: GrantFiled: August 4, 2010Date of Patent: October 9, 2012Assignee: Immunocore LimitedInventors: Bent Karsten Jakobsen, Nathaniel Ross Liddy
-
Patent number: 8217144Abstract: The present invention provides TCRs having an affinity (KD) of less than or equal to 3 ?M, and/or an off-rate (koff) of 1×10?3 S?1 or slower, for the AAGIGILTV-HLA-A*0201 complex. Such TCRs are useful, either alone or associated with a therapeutic agent, for targeting cancer cells presenting that complex.Type: GrantFiled: May 31, 2006Date of Patent: July 10, 2012Assignee: Immunocore Ltd.Inventors: Bent Karsten Jakobsen, Nathaniel Ross Liddy